Original research
by
Garg, Ria et al
Release Date
2022
Geography
Canada
Language of Resource
English
Full Text Available
Yes
Open Access / OK to Reproduce
No
Peer Reviewed
Yes
Objective
We assessed the impact of COVID-19, which includes the declaration of a state of emergency and subsequent release of pandemic-specific OAT guidance on the prevalence of OAT discontinuation.
Findings/Key points
Following COVID-19, there was no significant change in the percentage of Ontarians who discontinued OAT, regardless of whether they were stabilized on treatment. However, mortality following OAT discontinuation must be noted, as approximately 1.4% and 0.8% of people who discontinued methadone and buprenorphine/naloxone respectively, died within 30 days of discontinuation.
Design/methods
Population-based time series analysis
Keywords
Transitions in care/treatment
Mortality
Substitution/OAT
About PWUD
Outcomes
